Limitations in a frataxin knockdown cell model for Friedreich ataxia in a high-throughput drug screen

Limitations in a frataxin knockdown cell model for Friedreich ataxia in a high-throughput drug screen

<p>Abstract</p> <p>Background</p> <p>Pharmacological high-throughput screening (HTS) represents a powerful strategy for drug discovery in genetic diseases, particularly when the full spectrum of pathological dysfunctions remains unclear, such as in Friedreich ataxia (FR...

Full description

Bibliographic Details
Main Authors:	Haiech Jacques, Hibert Marcel, Reutenauer Laurence, Villa Pascal, Seznec Hervé, Calmels Nadège, Rustin Pierre, Koenig Michel, Puccio Hélène
Format:	Article
Language:	English
Published:	BMC 2009-08-01
Series:	BMC Neurology
Online Access:	http://www.biomedcentral.com/1471-2377/9/46

Similar Items

The first cellular models based on frataxin missense mutations that reproduce spontaneously the defects associated with Friedreich ataxia.
by: Nadège Calmels, et al.
Published: (2009-07-01)

Epigenetic modification of the frataxin gene for the treatment of Friedreich’s ataxia
by: Vilema Enriquez, MG
Published: (2018)

Simultaneous Quantification of Mitochondrial Mature Frataxin and Extra-Mitochondrial Frataxin Isoform E in Friedreich’s Ataxia Blood
by: Qingqing Wang, et al.
Published: (2022-04-01)

Strategies for increasing frataxin expression in Friedreich's ataxia: modulation of the epigenome and proteome
by: Quinlan, R
Published: (2021)

Novel frataxin isoforms may contribute to the pathological mechanism of Friedreich ataxia.
by: Haiyan Xia, et al.
Published: (2012-01-01)

DNA methylation in Friedreich ataxia silences expression of frataxin isoform E
by: Layne N. Rodden, et al.
Published: (2022-03-01)

Human frataxin, the Friedreich ataxia deficient protein, interacts with mitochondrial respiratory chain
by: Davide Doni, et al.
Published: (2023-12-01)

HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse model.
by: Myriam Rai, et al.
Published: (2008-01-01)

Development of frataxin gene expression measures for the evaluation of experimental treatments in Friedreich's ataxia.
by: Heather L Plasterer, et al.
Published: (2013-01-01)

Correction: Human frataxin, the Friedreich ataxia deficient protein, interacts with mitochondrial respiratory chain
by: Davide Doni, et al.
Published: (2024-01-01)

P003: Clinical laboratory experience of frataxin quantification in blood for the diagnosis of Friedreich ataxia*
by: Iris Pantovich, et al.
Published: (2024-01-01)

Frataxin deficiency alters gene expression in Friedreich ataxia derived IPSC‐neurons and cardiomyocytes
by: Mariana B. Angulo, et al.
Published: (2023-01-01)

High Levels of Frataxin Overexpression Lead to Mitochondrial and Cardiac Toxicity in Mouse Models
by: Brahim Belbellaa, et al.
Published: (2020-12-01)

Dimethyl fumarate dosing in humans increases frataxin expression: A potential therapy for Friedreich's Ataxia.
by: Mittal Jasoliya, et al.
Published: (2019-01-01)

Low apolipoprotein A-I levels in Friedreich's ataxia and in frataxin-deficient cells: Implications for therapy.
by: QingQing Wang, et al.
Published: (2018-01-01)

Recent Advances in the Elucidation of Frataxin Biochemical Function Open Novel Perspectives for the Treatment of Friedreich’s Ataxia
by: Beata Monfort, et al.
Published: (2022-03-01)

A Potential New Therapeutic Approach for Friedreich Ataxia: Induction of Frataxin Expression With TALE Proteins
by: Pierre Chapdelaine, et al.
Published: (2013-01-01)

An AAV9 coding for frataxin clearly improved the symptoms and prolonged the life of Friedreich ataxia mouse models
by: Catherine Gérard, et al.
Published: (2014-01-01)

Friedreich's ataxia: the vicious circle hypothesis revisited
by: Camadro Jean-Michel, et al.
Published: (2011-10-01)

Adding a temporal dimension to the study of Friedreich's ataxia: the effect of frataxin overexpression in a human cell model
by: Tommaso Vannocci, et al.
Published: (2018-06-01)

Frataxin gene editing rescues Friedreich’s ataxia pathology in dorsal root ganglia organoid-derived sensory neurons
by: Pietro Giuseppe Mazzara, et al.
Published: (2020-08-01)

Deferiprone targets aconitase: Implication for Friedreich's ataxia treatment
by: Rustin Pierre, et al.
Published: (2008-06-01)

Inhibition of the SUV4-20 H1 histone methyltransferase increases frataxin expression in Friedreich's ataxia patient cells
by: Vilema Enriquez, MG, et al.
Published: (2020)

Increased Frataxin Expression Induced in Friedreich Ataxia Cells by Platinum TALE-VP64s or Platinum TALE-SunTag
by: Khadija Cherif, et al.
Published: (2018-09-01)

Understanding the genetic and molecular pathogenesis of Friedreich’s ataxia through animal and cellular models
by: Alain Martelli, et al.
Published: (2012-03-01)

Clinical data and characterization of the liver conditional mouse model exclude neoplasia as a non-neurological manifestation associated with Friedreich’s ataxia
by: Alain Martelli, et al.
Published: (2012-11-01)

Highly specific ubiquitin-competing molecules effectively promote frataxin accumulation and partially rescue the aconitase defect in Friedreich ataxia cells
by: Alessandra Rufini, et al.
Published: (2015-03-01)

Neuroinflammation in Friedreich’s Ataxia
by: Savina Apolloni, et al.
Published: (2022-06-01)

Two new pimelic diphenylamide HDAC inhibitors induce sustained frataxin upregulation in cells from Friedreich's ataxia patients and in a mouse model.
by: Myriam Rai, et al.
Published: (2010-01-01)

Tissue Iron in Friedreich Ataxia
by: Arnulf H Koeppen
Published: (2024-01-01)

Respiratory Function in Friedreich’s Ataxia
by: Elena Vinante, et al.
Published: (2022-08-01)

The pathogenesis of cardiomyopathy in Friedreich ataxia.
by: Arnulf H Koeppen, et al.
Published: (2015-01-01)

Mitochondrial damage and senescence phenotype of cells derived from a novel frataxin G127V point mutation mouse model of Friedreich's ataxia
by: Daniel Fil, et al.
Published: (2020-07-01)

Mammalian frataxin: an essential function for cellular viability through an interaction with a preformed ISCU/NFS1/ISD11 iron-sulfur assembly complex.
by: Stéphane Schmucker, et al.
Published: (2011-01-01)

Friedreich ataxia in a family from Mali, West Africa/Friedreich ataxia in a Malian family
by: Cheick A. K. Cissé, et al.
Published: (2021-05-01)

Dysregulation of cellular iron metabolism in Friedreich ataxia: from primary iron-sulfur cluster deficit to mitochondrial iron accumulation
by: Alain eMartelli, et al.
Published: (2014-06-01)

Friedreichs ataxia in a diabetic patient
by: Inna Igorevna Klefortova, et al.
Published: (2010-06-01)

Emerging antioxidant therapies in Friedreich’s ataxia
by: Fred Jonathan Edzeamey, et al.
Published: (2024-02-01)

An Overview of the Ferroptosis Hallmarks in Friedreich’s Ataxia
by: Riccardo Turchi, et al.
Published: (2020-10-01)

Neuro-Ophthalmological Findings in Friedreich’s Ataxia
by: Pilar Rojas, et al.
Published: (2021-07-01)